Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.  

The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.

Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.

“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”


Read more: 

 Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Go Back

Share this story

Comments


Related articles


blogger

Interviews

“Life can still be fun if you have Parkinson’s”

The latest in our monthly series profiling WPC2019 bloggers

READ MORE
Moving Through Glass demo

Advances

Save the last dance for Google Glass

How innovative software is helping patients dance off symptoms

READ MORE

Advances

Parkinson’s UK to launch largest plant-based oil trial in the world

The trial will be carried out over three years

READ MORE